Bio-Techne Invests in Cell Culture Products: Company expands product offerings

摘要

Minneapolis, MN 1/2/18 - Bio-Techne, a provider of products for scientific investigation, has purchased Atlanta Biologicals and its Scientific Ventures affiliate for cash. Other financial details were not disclosed. Atlanta Biologicals sells cell culture sera, media and reagents. The company has around 25 employees. "Atlanta Biologicals is a great fit with the Bio-Techne product portfolio as we continue to expand our cell culture and tissue regeneration capabilities," stated Bio-Techne President and CEO Charles R. Kummeth. "Many of our products are used in tissue culture applications, and the Atlanta Biologicals Fetal Bovine Serum (FBS) product line strengthens and complements our current tissue culture reagents offering and furthers our efforts to provide more complete solutions to our research customers," he said. "With the increasing interest in 3D cell cultures and other cell-based clinical applications, we believe there is value in providing customers alternative and reliable sources of high-quality FBS and other tissue culture reagents." The transaction is expected to be slightly accretive to Bio-Techne's fiscal 2018 adjusted EPS.